What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the current subscription status of Metropolis Healthcare Limited IPO?

Metropolis Healthcare Limited IPO has received a total subscription of 0.00 times overall.

IPO GreyPremiumLIVE

Grey Market Intelligence

Metropolis Healthcare Limited

ListedMainboard

Healthcare · NSE / BSE

Incorporated in 1980, Mumbai-based Metropolis Healthcare Limited is a chain of diagnostic companies operating 106 clinical laboratories and 1,130 collection centers across seven countries, with a presence in 18 states and 173 cities in India for disease monitoring, early detection, and diagnostic screening. The company offers 3,480 clinical laboratory tests and 524 profiles, combining various tests for specific diseases, and serves around 7.7 million patients annually, conducting approximately 16 million tests. It also provides analytical and support services for clinical research projects and follows a 'hub and spoke' model to enhance service delivery. Internationally, Metropolis has laboratory operations in Ghana, Zambia, Kenya, Sri Lanka, and Mauritius, and offers third-party services in UAE, Nepal, Nigeria, and Oman. The company has been recognized for excellence in customer service and delivery by Biotrains, for service excellence by FICCI, and as "best in health and fitness" by LH Insights in 2018.

Price Band

₹877 – ₹880

Issue Size

₹1204 Cr

Lot Size

17 shares

GMP

—

Est. Listing

₹880

at current GMP

Subscribed

—

Open

3 Apr 2019

5 Apr 2019

Allotment

10 Apr 2019

Refund

11 Apr 2019

Demat Credit

12 Apr 2019

Listing

15 Apr 2019

Last updated 12 days ago

Overview Live GMP Subscription Status Allotment Status Filing Documents

Overall Subscription

0.00x

Total Demand

QIB Multiplier

0.00x

Institutions & Funds

NII / HNI

0.00x

High Net-Worth

Retail (RII)

0.00x

Individual Bidders

Category-Wise Subscription Breakup

Live bidding breakdown by institutional, non-institutional, and retail investors

Total 0.00x

Category	Shares Offered	Shares Applied / Bid	Times Subscribed
Qualified Institutional (QIB)	6,840,909	—	0.00x
Non-Institutional (NII / HNI)	2,052,273	—	0.00x
Retail Individual (RII)	4,788,636	—	0.00x
Total	13,681,818	0	0.00x

Application-Wise Breakup

Total unique applications received across retail and HNI tranches

Apps 1.00x

Category	Applications Reserved	Applications Received	Times Subscribed
Retail (RII)	281,684	281,684	1.00x
HNIs (10L +)	1,802	1,802	1.00x
HNIs (2-10L)	8,623	8,623	1.00x
Total Applications	292,109	292,109	1.00x

Day-Wise Subscription Progress

Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.

About Metropolis Healthcare Limited Public Issue & Market Profile

Metropolis Healthcare Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹1,204 Crores. The shares are offered at a price band of ₹877 to ₹880 per equity share on NSE and BSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.

Bidding & Quota Instructions:

The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.

Allotment Reconciliation Schedule:

Following the close of bidding on 2019-04-05, the basis of allotment is scheduled to be finalized on 2019-04-10. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Link Intime India Private Ltd) or the BSE allotment checking window.

Frequently Asked Questions

What is Metropolis Healthcare Limited IPO GMP today?

Currently, Metropolis Healthcare Limited IPO Grey Market Premium (GMP) is not actively quoted or is quoted flat at ₹0. The shares are expected to list close to the issue price band of ₹877 to ₹880 per equity share.

What is the expected profit per lot for Metropolis Healthcare Limited IPO?

The retail lot size is 17 shares requiring a minimum application amount of ₹14,960. Expected listing price is ₹880 per equity share.

What is the issue size and price band for Metropolis Healthcare Limited IPO?

The Metropolis Healthcare Limited IPO aggregate issue size is ₹1,204 Crores with an equity price band set at ₹877 to ₹880 per equity share. The retail lot size is 17 shares requiring a minimum capital outlay of approx. ₹14,960.

How can I check Metropolis Healthcare Limited IPO live subscription demand?

Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 0.00x (Retail: 0.00x, QIB: 0.00x, NII: 0.00x). You can track live multiples directly on our dedicated subscription page.

Where and when will Metropolis Healthcare Limited IPO allotment status be published?

The basis of allotment will be published on the official registrar portal (Link Intime India Private Ltd) and the BSE status verification website on or around 2019-04-10. Investors can verify status using PAN card or application number.

When is the listing date for Metropolis Healthcare Limited IPO?

Metropolis Healthcare Limited shares are scheduled to list on NSE and BSE on 2019-04-15.